Lee Horobin - TBG Diagnostics Insider

TBG Diagnostics Limited -- Australia Stock  

 0.16  0.00  0.00%

General Manager of Fin.

Mr. Lee Horobin serves as General Manager Finance of Progen Pharmaceuticals Limited since August 23 2012. He served as Company Secretary from March 1 2010 to May 24 2010 and Acting General Manager Finance from March 1 2010 to May 2010. He has commenced with Progen on an interim basis due to an extended period of absence of Mr. Paul Dixon
  Executive Since 2012  CPA    
61 7 3273 9133  http://www.tbgbio.com
Horobin is a member of CPA Australia and has held company secretarial positions in previous roles.

Management Efficiency

The company has return on total asset (ROA) of (47.62) % which means that it has lost $47.62 on every $100 spent on asset. This is way below average.

Similar Executives

Showing few of many executives

EXECUTIVE Since

Vittoria ShorttCommonwealth Bank of Australia
2015
Joanne FarrellRio Tinto Limited
2016
David LindbergWestpac Banking Corporation
2015
Bold BaatarRio Tinto Limited
2016
Vera KirikovaRio Tinto Limited
2017
Matthew ComynCommonwealth Bank of Australia
2012
Tim BultWesfarmers Limited
2015
Rebecca LimWestpac Banking Corporation
2017
Maya DriesenWesfarmers Limited
2015
David CurranWestpac Banking Corporation
2014
Dave BComWestpac Banking Corporation
N/A
Mark ShannonRio Tinto Limited
N/A
Eleanor EvansRio Tinto Limited
2013
Tara DinesBHP Billiton Limited
N/A
Hugo BagueRio Tinto Limited
2013
Simon TrottRio Tinto Limited
2017
Carla CollingwoodCommonwealth Bank of Australia
2005
Simone NivenRio Tinto Limited
2017
Margaret TaylorBHP Billiton Limited
2015
Geoff HealyBHP Billiton Limited
2016
Harry KenyonSlaneyRio Tinto Limited
2012

Entity Summary

TBG Diagnostics Limited, a biotechnology company, focuses on the development, manufacture, and marketing of nucleic acid test kits. TBG Diagnostics Limited (PGL) is traded on Australian Securities Exchange in Australia. It is located in Darra, QLD and employs 10 people.

Did you try this?

Run Pair Correlation Now
   

Pair Correlation

Compare performance and examine historical correlation between any two equity instruments
Hide  View All  NextLaunch Pair Correlation
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add TBG Diagnostics Limited to your portfolio

Top Management

TBG Diagnostics Limited Leadership Team
Keith Dredge, Director, Ph.D
YuZen Cheng, Director
Lee Horobin, Executive, CPA
Generosa Hipona, Executive
Blair Lucas, Executive
Hongjen Chang, Director
Fleur Lankesheer, Director
Leslie Tillack, CEO
ChiaChuan Chang, Director
ShiChung Chang, Director, Ph.D
Indrajit Arulampalam, Chairman
Emily Lee, Director
Christopher Harvey, Director

Stock Performance

TBG Diagnostics Performance Indicators